Bone Biologics Corporation (BBLG) Stock Split, History Data
Working capital analysis
In terms of working capital, Bone Biologics Corporation maintains a healthy position.
The total current assets of the company are valued at $3737763.
This represents a growth rate of -56.002% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $3026569, exhibiting a growth rate of -59.851% year-on-year.
The receivables, another significant portion of the current assets, are valued at $328844.
The year-on-year growth rate for receivables is -43.294%.
The inventory, which forms a critical part of the assets, is valued at $-328844.
This represents a healthy year-on-year growth of -43.294%
On the liabilities side, the company's current liabilities total $831402.
This reflects a growth rate of -67.369% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
3.03
7.54
6.68
0.00
0.02
0.96
Receavebles
0.33
0.58
0.00
0.00
0.00
0.00
Inventory
0.33
0.58
0.00
0.00
0.00
0.00
Other
0.71
0.96
0.00
0.00
0.01
0.09
Total Current Assets
3.74
8.50
6.68
0.00
0.03
1.04
Acc Payable
0.36
0.00
0.10
0.47
0.04
0.13
Short Term Debt
0.00
0.78
0.00
11.72
0.00
9.00
Other Current Liab
0.47
2.55
0.00
1.50
0.54
0.51
Current Liabilities
0.83
2.55
0.10
13.69
0.58
9.64
Capital Structure
When examining the capital structure of Bone Biologics Corporation, it is clear that the company manages a robust portfolio.
These earnings represent the profits that Bone Biologics Corporation has chosen to reinvest in the business rather than distribute as dividends.
